CLINICAL_TRIALS ClinicalTrials.gov record update

XanaHES: A Phase I, Single Blinded, Central Reader Blinded, Placebo-Controlled, Dose Escalation Study of Xanamem™ to Assess Safety and Tolerability in Healthy Elderly Subjects

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03830762
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:57.905945+00:00
Published At: 2025-01-22T00:00:00+00:00
Record Updated At: 2025-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Safety", "Peripheral Neuropathy", "Cortisol", "Central Nervous System", "Cognitive Function", "Healthy Ageing", "Small Fibre Neuropathy", "Cerebrospinal Fluid", "Electrocardiography"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-22"
protocolSection.identificationModule.nctId: "NCT03830762"
protocolSection.identificationModule.officialTitle: "XanaHES: A Phase I, Single Blinded, Central Reader Blinded, Placebo-Controlled, Dose Escalation Study of Xanamem\u2122 to Assess Safety and Tolerability in Healthy Elderly Subjects"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.